Explore articles, research, and perspectives from the International Perfusion Association.
A small CABG cohort found similar early recovery after prior asymptomatic COVID-19 but more postoperative complications, with important limits on timing conclusions.
This study assesses the durability of the original monovalent mRNA COVID-19 vaccine in preventing hospitalization due to the Omicron variant among U.S. children aged
This study characterizes the burden and outcomes of ECMO use in U.S. hospitalizations during the pandemic, analyzing 17,520 cases from the National Inpatient Sample
This nationwide study in Korea explored the mortality risk factors for COVID-19 patients needing Extracorporeal Membrane Oxygenation (ECMO) support across 19 hospitals from January
This study investigates the incidence and microbiology of healthcare-associated infections (HAI) in severe COVID-19 patients receiving extracorporeal membrane oxygenation (ECMO) support, analyzing data from
This meta-analysis explores the impact of pre-ECMO timing and ECMO duration on the survival of severe COVID-19 patients, analyzing 54 studies involving 13,691 patients.
The study developed and validated RIETS, a machine learning-based system using 11 routine clinical and laboratory biomarkers to predict COVID-19 severity upon hospitalization, showing
This study compared prehospital care, in-hospital treatment, and outcomes among out-of-hospital cardiac arrest (OHCA) patients before and after the COVID-19 pandemic, revealing that survival
Six months after hospital discharge, patients with severe COVID-19 who received veno-venous extracorporeal membrane oxygenation (V-V ECMO) showed persistent impairments in small airway function
This study analyzed the mean cost of inpatient care for COVID-19 patients in the US from March 2020 to March 2022, finding an overall
On December 6, 2023, Florida State Surgeon General Dr. Joseph A. Ladapo raised concerns to the FDA and CDC about potential nucleic acid contaminants
This study explores attitudes toward COVID-19 and influenza vaccines among US adults. The data comes from a July 2023 survey of 1430 US adults,
